Literature DB >> 26179552

Laparoscopic sacral hysteropexy versus laparoscopic sacrocolpopexy with hysterectomy for pelvic organ prolapse.

Ke Pan1, Lili Cao1, Nicholas A Ryan2, Yanzhou Wang1, Huicheng Xu3.   

Abstract

INTRODUCTION AND HYPOTHESIS: Treating pelvic organ prolapse (POP) with uterine conservation and sacral hysteropexy has uncertain subjective and objective outcomes. We sought to compare laparoscopic sacral hysteropexy with laparoscopic sacrocolpopexy/total laparoscopic hysterectomy (TLH with LSC).
METHODS: Clinical data of 34 patients who underwent TLH with LSC and 65 patients who underwent laparoscopic sacral hysteropexy performed by the same group of surgeons between January 2008 and December 2013 were reviewed retrospectively. The primary outcome was subjective satisfaction rate based upon validated questionnaire (Patient Global Impression of Change [PGI-C]). Secondary outcomes were: anatomical cure, impact on quality of life based upon validated questionnaires (pelvic floor distress inventory-short form 20 [PFDI-20], Pelvic Floor Impact Questionnaire 7 [PFIQ-7], and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12 [PISQ-12]), surgical complications, and cost.
RESULTS: After a mean follow-up of 33 months, the subjective satisfaction rate was significantly higher in the TLH with LSC cohort (92.3% vs 100%; p < 0.001). The POP-Q scores in both groups were significantly improved postoperatively. However, the anatomical cure in the two groups (72.3% vs 88.2%; p = 0.07) did not differ significantly The postoperative PFIQ-7 and PFDI-20 scores were significantly better in the TLH with LSC cohort than in the laparoscopic sacral hysteropexy cohort (p = 0.043 and p = 0.035 respectively).
CONCLUSIONS: Relative to laparoscopic sacral hysteropexy, the TLH with LSC approach provides similar anatomical results, excellent patient satisfaction, and improved quality of life scores.

Entities:  

Keywords:  Laparoscopic; Objective success; Sacral hysteropexy; Sacrocolpopexy; Subjective satisfaction; Uterine prolapse

Mesh:

Year:  2015        PMID: 26179552     DOI: 10.1007/s00192-015-2775-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  26 in total

1.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

2.  Anatomic outcomes of vaginal mesh procedure (Prolift) compared with uterosacral ligament suspension and abdominal sacrocolpopexy for pelvic organ prolapse: a Fellows' Pelvic Research Network study.

Authors:  Tatiana V D Sanses; Azin Shahryarinejad; Stephanie Molden; Kay A Hoskey; Shameem Abbasy; Danielle Patterson; Emily K Saks; Emily E Weber LeBrun; Tondalaya L Gamble; Virginia G King; Aimee L Nguyen; Husam Abed; Stephen B Young
Journal:  Am J Obstet Gynecol       Date:  2009-08-28       Impact factor: 8.661

3.  Sacrohysteropexy with synthetic mesh for the management of uterovaginal prolapse.

Authors:  E Leron; S L Stanton
Journal:  BJOG       Date:  2001-06       Impact factor: 6.531

4.  Short-term outcomes of robotic versus conventional laparoscopic sacral colpopexy.

Authors:  Danielle D Antosh; Stephanie A Grotzke; Marcela A McDonald; David Shveiky; Amy J Park; Robert E Gutman; Andrew I Sokol
Journal:  Female Pelvic Med Reconstr Surg       Date:  2012 May-Jun       Impact factor: 2.091

5.  Laparoscopic modified sacral hysteropexy: initial experience with an original surgical approach to uterovaginal prolapse.

Authors:  Lin Lin; Ping Wang; Qilin Wang; Tianjin Yi
Journal:  J Minim Invasive Gynecol       Date:  2013-11-27       Impact factor: 4.137

6.  Abdominal sacrohysteropexy in young women with uterovaginal prolapse: long-term follow-up.

Authors:  Emmanuel Barranger; Xavier Fritel; Alain Pigne
Journal:  Am J Obstet Gynecol       Date:  2003-11       Impact factor: 8.661

7.  Patient preferences for uterine preservation and hysterectomy in women with pelvic organ prolapse.

Authors:  Nicole B Korbly; Nadine C Kassis; Meadow M Good; Monica L Richardson; Nicole M Book; Sallis Yip; Docile Saguan; Carey Gross; Janelle Evans; Vrishali V Lopes; Heidi S Harvie; Vivian W Sung
Journal:  Am J Obstet Gynecol       Date:  2013-08-03       Impact factor: 8.661

8.  Risk factors for mesh/suture erosion following sacral colpopexy.

Authors:  Geoffrey W Cundiff; Edward Varner; Anthony G Visco; Halina M Zyczynski; Charles W Nager; Peggy A Norton; Joseph Schaffer; Morton B Brown; Linda Brubaker
Journal:  Am J Obstet Gynecol       Date:  2008-10-31       Impact factor: 8.661

9.  Vaginal sacrospinous colpopexy and laparoscopic sacral colpopexy for vaginal vault prolapse.

Authors:  J Marcickiewicz; M Kjöllesdal; M Ellström Engh; S Eklind; C Axén; M Brännström; J-H Stjerndahl
Journal:  Acta Obstet Gynecol Scand       Date:  2007       Impact factor: 3.636

10.  Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy.

Authors:  Jasmine Tan-Kim; Shawn A Menefee; Karl M Luber; Charles W Nager; Emily S Lukacz
Journal:  Int Urogynecol J       Date:  2010-09-15       Impact factor: 2.894

View more
  16 in total

1.  Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.

Authors:  Christine Hemming; Lynda Constable; Beatriz Goulao; Mary Kilonzo; Dwayne Boyers; Andrew Elders; Kevin Cooper; Anthony Smith; Robert Freeman; Suzanne Breeman; Alison McDonald; Suzanne Hagen; Isobel Montgomery; John Norrie; Cathryn Glazener
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

2.  One-Year Outcomes After Minimally Invasive Sacrocolpopexy.

Authors:  Kimberly Kenton; Elizabeth R Mueller; Christopher Tarney; Catherine Bresee; Jennifer T Anger
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Sep-Oct       Impact factor: 2.091

3.  Robotic or laparoscopic sacrohysteropexy versus open sacrohysteropexy for uterus preservation in pelvic organ prolapse.

Authors:  Jiheum Paek; Maria Lee; Bo Wook Kim; Yongil Kwon
Journal:  Int Urogynecol J       Date:  2015-10-29       Impact factor: 2.894

4.  Joint report on terminology for surgical procedures to treat pelvic organ prolapse.

Authors: 
Journal:  Int Urogynecol J       Date:  2020-03       Impact factor: 2.894

Review 5.  Role of Hysteropexy in the Management of Pelvic Organ Prolapse.

Authors:  Zoe S Gan; Daniel S Roberson; Ariana L Smith
Journal:  Curr Urol Rep       Date:  2022-07-05       Impact factor: 2.862

Review 6.  Mesh exposure following minimally invasive sacrocolpopexy: a narrative review.

Authors:  Stephanie Deblaere; Jan Hauspy; Karen Hansen
Journal:  Int Urogynecol J       Date:  2022-02-28       Impact factor: 1.932

7.  Sexual activity and function in women with advanced stages of pelvic organ prolapse, before and after laparoscopic or vaginal mesh surgery.

Authors:  Sònia Anglès-Acedo; Cristina Ros-Cerro; Sílvia Escura-Sancho; M José Palau-Pascual; Eduardo Bataller-Sánchez; Montserrat Espuña-Pons; Francisco Carmona-Herrera
Journal:  Int Urogynecol J       Date:  2020-08-07       Impact factor: 2.894

8.  Complications and reoperations after laparoscopic sacrocolpopexy with a mean follow-up of 4 years.

Authors:  David Vandendriessche; Julie Sussfeld; Géraldine Giraudet; Jean-Philippe Lucot; Hélène Behal; Michel Cosson
Journal:  Int Urogynecol J       Date:  2016-08-22       Impact factor: 2.894

9.  Laparoscopic minimally invasive sacrocolpopexy or hysteropexy and transobturator tape combined with native tissue repair of the vaginal compartments in patients with advanced pelvic organ prolapse and incontinence.

Authors:  Ivan Ignjatovic; Milan Potic; Dragoslav Basic; Ljubomir Dinic; Aleksandar Skakic
Journal:  Int Urogynecol J       Date:  2020-09-08       Impact factor: 2.894

Review 10.  Hysteropexy: an Option for the Repair of Pelvic Organ Prolapse.

Authors:  Sarah Bradley; Robert E Gutman; Lee A Richter
Journal:  Curr Urol Rep       Date:  2018-02-23       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.